The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 22, 2022

Filed:

Aug. 27, 2018
Applicant:

Amgen Inc., Thousand Oaks, CA (US);

Inventors:

Sean P. Brown, San Francisco, CA (US);

Yunxiao Li, Thousand Oaks, CA (US);

Paul E. Harrington, Thousand Oaks, CA (US);

Brian Alan Lanman, Woodland Hills, CA (US);

Jonathan D. Low, Reseda, CA (US);

Ana Elena Minatti, Los Angeles, CA (US);

Vu Van Ma, Oak Park, CA (US);

Kexue Li, Newbury Park, CA (US);

Assignee:

AMGEN INC., Thousand Oaks, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 513/04 (2006.01); C07D 513/08 (2006.01); C07D 519/00 (2006.01); A61P 35/00 (2006.01); A61K 31/496 (2006.01); A61K 31/5377 (2006.01); A61K 31/7068 (2006.01);
U.S. Cl.
CPC ...
C07D 513/04 (2013.01); A61P 35/00 (2018.01); C07D 519/00 (2013.01); A61K 31/496 (2013.01); A61K 31/5377 (2013.01); A61K 31/7068 (2013.01);
Abstract

Provided herein are myeloid cell leukemia 1 protein (Mcl-1) inhibitors, methods of their preparation, related pharmaceutical compositions, and methods of using the same. For example, provided herein are compounds of Formula I, or a stenoisomer thereof; and pharmaceutically acceptable salts thereof and pharmaceutical compositions containing the compounds. The compounds and compositions provided herein may be used, for example, in the treatment of diseases or conditions, such as cancer.


Find Patent Forward Citations

Loading…